Filing Details
- Accession Number:
- 0001225208-22-007104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-17 07:48:23
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-17 07:48:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1805617 | B. Jennifer Damico | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-05-16 | 4,000 | $50.50 | 15,064 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock Units SSP | Acquisiton | 2022-05-13 | 26 | $49.92 | 26 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,935 | No | 4 | A | Direct |
Footnotes
- Each unit represents one phantom share of common stock.
- These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.